Denver, CO, United States of America

Steve Mark Helmke

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Englewood, CO (US) (2003)
  • Denver, CO (US) (2015 - 2024)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations in Liver Disease Treatment by Steve Mark Helmke

Introduction

Steve Mark Helmke is a prominent inventor based in Denver, Colorado, known for his significant contributions to the field of liver disease treatment. With a total of 10 patents to his name, Helmke has developed innovative methods that enhance the diagnosis and management of chronic liver conditions.

Latest Patents

Helmke's latest patents include groundbreaking methods for monitoring the treatment of chronic liver disease. One of his notable inventions is a Disease Severity Index (DSI), which assesses chronic liver disease in patients using non-invasive liver function test results. This DSI is derived from hepatic blood flow data and is instrumental in predicting clinical outcomes, responses to antiviral treatments, and the progression of chronic liver diseases. Additionally, he has developed non-invasive methods to categorize patients with Primary Sclerosing Cholangitis (PSC) into Slow Progressors, Moderate Progressors, and Rapid Progressors. Another significant patent involves a method for assessing hepatic function and portal blood flow, utilizing a simplified in vitro test called the STAT test. This test estimates portal blood flow from a single blood sample taken after administering deuterated-cholate, making it a valuable tool for patients with chronic liver diseases.

Career Highlights

Helmke's career is marked by his dedication to advancing medical technology and improving patient outcomes. His work at the University of Colorado has positioned him as a leader in liver disease research and innovation. His patents reflect a commitment to developing non-invasive diagnostic methods that can significantly impact patient care.

Collaborations

Helmke has collaborated with esteemed colleagues such as Gregory Thomas Everson and Karl Pfenninger, contributing to a rich environment of research and innovation in the field of liver disease.

Conclusion

Steve Mark Helmke's contributions to the field of liver disease treatment through his innovative patents demonstrate his commitment to improving patient care and advancing medical technology. His work continues to influence the diagnosis and management of chronic liver conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…